FDA drug reviewers are immune from legal liability, but they may be reproached and humiliated by congressional hearings, television exposés, and newspaper condemnations. Why don’t congressional representatives, television reporters, and newspaper columnists bring the deadly consequences of FDA delay to light? Answer: When the side effects of a new drug cause little Tommy of 236 … Continue reading Why the FDA Has an Incentive to Delay the Introduction of New Drugs